FDA Approved: PIOGLITAZONE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Pioglitazone from NorthStar RxLLC, authorizing the generic product under ANDA 202467.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

SUPPL AP for PIOGLITAZONE (PIOGLITAZONE)